GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (OTCPK:GNIIF) » Definitions » EV-to-EBIT

GNI Group (GNI Group) EV-to-EBIT : 6.69 (As of May. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is GNI Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, GNI Group's Enterprise Value is $647.2 Mil. GNI Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $96.8 Mil. Therefore, GNI Group's EV-to-EBIT for today is 6.69.

The historical rank and industry rank for GNI Group's EV-to-EBIT or its related term are showing as below:

GNIIF' s EV-to-EBIT Range Over the Past 10 Years
Min: -698.27   Med: 19.65   Max: 559.71
Current: 7.37

During the past 13 years, the highest EV-to-EBIT of GNI Group was 559.71. The lowest was -698.27. And the median was 19.65.

GNIIF's EV-to-EBIT is ranked better than
53.65% of 425 companies
in the Biotechnology industry
Industry Median: 9.54 vs GNIIF: 7.37

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. GNI Group's Enterprise Value for the quarter that ended in Dec. 2023 was $524.8 Mil. GNI Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $96.8 Mil. GNI Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 18.44%.


GNI Group EV-to-EBIT Historical Data

The historical data trend for GNI Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group EV-to-EBIT Chart

GNI Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.11 37.51 32.75 33.14 8.93

GNI Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.14 29.42 9.05 11.67 8.93

Competitive Comparison of GNI Group's EV-to-EBIT

For the Biotechnology subindustry, GNI Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where GNI Group's EV-to-EBIT falls into.



GNI Group EV-to-EBIT Calculation

GNI Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=647.163/96.791
=6.69

GNI Group's current Enterprise Value is $647.2 Mil.
GNI Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $96.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GNI Group  (OTCPK:GNIIF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

GNI Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=96.791/524.81952521
=18.44 %

GNI Group's Enterprise Value for the quarter that ended in Dec. 2023 was $524.8 Mil.
GNI Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $96.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GNI Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of GNI Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


GNI Group (GNI Group) Business Description

Traded in Other Exchanges
Address
Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (GNI Group) Headlines